First FDA-Approved Hypersomnia Drug Data Published : compare

Lower-sodium oxybate improves idiopathic hypersomnia symptoms and might be a useful first-line therapy or monotherapy or used in combination with alerting agents, newly published data show.

Related Keywords

Georgia , United States , France , Emory University School Of Medicine , Atlanta , Lynn Marie Trotti , Yves Dauvilliers , Department Of Neurology , Wake Disorders Center , Jazz Pharmaceuticals , Drug Administration , Epworth Sleepiness Scale , Gui De Chauliac Hospital , Cautionary Notes , Marie Trotti , Sleep Center , Emory University School , Sleep Disorder , Select Sleep Disorders , Narcolepsy , Cataplexy , Insomnia , Idiopathic Hypersomnia , Excessive Daytime Sleepiness , Obstructive Sleep Apnea , Sleep , Hypersomnia ,